Ben Reguiga M, Bonhomme-Faivre L, Orbach-Arbouys S, Farinotti R
Pharm Res. 2005; 22(11):1829-36.
PMID: 16151670
DOI: 10.1007/s11095-005-7415-5.
Yang J, Maarek J, Holschneider D
Lab Anim. 2005; 39(3):259-68.
PMID: 16004684
PMC: 4100546.
DOI: 10.1258/0023677054307033.
Daluge S, Good S, Faletto M, Miller W, St Clair M, BOONE L
Antimicrob Agents Chemother. 1997; 41(5):1082-93.
PMID: 9145874
PMC: 163855.
DOI: 10.1128/AAC.41.5.1082.
Nair V, St Clair M, Reardon J, Krasny H, Hazen R, Paff M
Antimicrob Agents Chemother. 1995; 39(9):1993-9.
PMID: 8540705
PMC: 162870.
DOI: 10.1128/AAC.39.9.1993.
Frick L, St John L, Taylor L, Painter G, Furman P, Liotta D
Antimicrob Agents Chemother. 1993; 37(11):2285-92.
PMID: 8285607
PMC: 192380.
DOI: 10.1128/AAC.37.11.2285.
5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.
Baccanari D, Davis S, Knick V, Spector T
Proc Natl Acad Sci U S A. 1993; 90(23):11064-8.
PMID: 8248211
PMC: 47922.
DOI: 10.1073/pnas.90.23.11064.
Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs.
Mizojiri K, Futaguchi S, Norikura R, Katsuyama Y, Nagasaki T, Yoshimori T
Antimicrob Agents Chemother. 1995; 39(7):1445-53.
PMID: 7492083
PMC: 162760.
DOI: 10.1128/AAC.39.7.1445.
Transplacental stimulation of lung development in the fetal rabbit by 3,5-dimethyl-3'-isopropyl-L-thyronine.
Ballard P, Benson B, Brehier A, Carter J, Kriz B, Jorgensen E
J Clin Invest. 1980; 65(6):1407-17.
PMID: 7410548
PMC: 371479.
DOI: 10.1172/JCI109805.
The metabolic and pharmacokinetic disposition of mebendazole in the rat.
Allan R, Watson T
Eur J Drug Metab Pharmacokinet. 1983; 8(4):373-81.
PMID: 6673974
DOI: 10.1007/BF03188769.
4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole.
Dawson M, Watson T
Eur J Drug Metab Pharmacokinet. 1983; 8(4):329-34.
PMID: 6673970
DOI: 10.1007/BF03188765.
Studies on the disposition of a 5-nitroimidazole in laboratory animals.
Barrow A, Burford S, Forrest T, Hawkins A, ROSE D, Stevens P
Eur J Drug Metab Pharmacokinet. 1987; 12(2):85-90.
PMID: 3121339
DOI: 10.1007/BF03189881.
The pharmacokinetics of aspirin in rats and the effect of buffer.
Fu C, Melethil S, Mason W
J Pharmacokinet Biopharm. 1991; 19(2):157-73.
PMID: 2013838
DOI: 10.1007/BF01073867.
Metabolic disposition and pharmacokinetics of the antiviral agent 6-methoxypurine arabinoside in rats and monkeys.
Burnette T, Koszalka G, KRENITSKY T, de Miranda P
Antimicrob Agents Chemother. 1991; 35(6):1165-73.
PMID: 1929259
PMC: 284305.
DOI: 10.1128/AAC.35.6.1165.
Influence of permanent cannulation of the jugular vein on pharmacokinetics of amoxycillin and antipyrine in the rat.
Torres-Molina F, Aristorena J, Granero L
Pharm Res. 1992; 9(12):1587-91.
PMID: 1488402
DOI: 10.1023/a:1015864425069.
Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
Lambe C, Resetar A, Spector T, Koszalka G, Nelson D
Antimicrob Agents Chemother. 1992; 36(2):353-60.
PMID: 1318679
PMC: 188441.
DOI: 10.1128/AAC.36.2.353.
Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat.
Dahlstrom B, Paalzow L
J Pharmacokinet Biopharm. 1978; 6(6):505-19.
PMID: 731414
DOI: 10.1007/BF01062106.
The effects of hypoglycin on glucose metabolism in the rat. A kinetic study in vivo and [U-14C,2-3H]glucose.
Osmundsen H, Billington D, Taylor J, Sherratt H
Biochem J. 1978; 170(2):337-42.
PMID: 637848
PMC: 1183900.
DOI: 10.1042/bj1700337.
Pharmacokinetics of clonidine in the rat and cat.
Paalzow L, Edlund P
J Pharmacokinet Biopharm. 1979; 7(5):481-94.
PMID: 529018
DOI: 10.1007/BF01062390.